This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Efficacy of a Cephalic Mask for Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure

This study has been terminated.
Information provided by:
University Hospital, Rouen Identifier:
First received: September 13, 2005
Last updated: February 14, 2012
Last verified: February 2012

Noninvasive ventilation (NIV) is now a major therapeutic option to manage patients with acute hypercapnic respiratory failure (AHRF). Otherwise, patient-ventilator interfaces are determinant to get an optimal NIV efficacy in parallel with ventilatory comfort.

Facial masks during NIV are associated with deleterious consequences like gas leaks around the mask, skin breakdown (especially on the nasal bridge), claustrophobia and mask discomfort. In order to limit these side effects, a cephalic interface has been recently designed. Cephalic mask covers the whole anterior surface of the face and excessive mask fit pressure is therefore spread over a larger surface outside the nose area. However, this mask has a high volume that may interfere with NIV efficacy and may also induce claustrophobic sensations.

The aim of this study is to compare the clinical efficacy and tolerance of a cephalic mask versus a conventional oronasal mask during AHRF.

Condition Intervention
Acute Hypercapnic Respiratory Failure Device: Interface for noninvasive ventilation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by University Hospital, Rouen:

Primary Outcome Measures:
  • Arterial blood gases

Secondary Outcome Measures:
  • Respiratory frequency
  • Severity scores
  • Ventilatory settings
  • Patient-ventilator adaptation
  • Tolerance
  • Outcome
  • Complications

Study Start Date: October 2004
Estimated Study Completion Date: February 2006

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Acute hypercapnic respiratory failure
  • Indication to noninvasive ventilation

Exclusion Criteria:

  • Requirement for endotracheal intubation
  • Proven pulmonary embolism
  • Present or previous history of ophthalmologic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00213395

Pulmonary & Intensive Care Department - Rouen University Hospital,
Rouen, France, 76031
Sponsors and Collaborators
University Hospital, Rouen
Principal Investigator: Antoine CUVELIER, MD, PhD University Hospital, Rouen
  More Information Identifier: NCT00213395     History of Changes
Other Study ID Numbers: 2004/015/HP
Study First Received: September 13, 2005
Last Updated: February 14, 2012

Keywords provided by University Hospital, Rouen:
Noninvasive ventilation
Acute hypercapnic respiratory failure
Cephalic mask
Facial Mask

Additional relevant MeSH terms:
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms processed this record on September 20, 2017